|
Volumn 11, Issue 4, 2010, Pages 246-248
|
NF-κB: No longer an island, but a piece of a continent
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LYMPHOTOXIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
REACTIVE OXYGEN METABOLITE;
SALICYLIC ACID DERIVATIVE;
STEROID HORMONE RECEPTOR BLOCKING AGENT;
SUMO PROTEIN;
TOLL LIKE RECEPTOR;
TUMOR NECROSIS FACTOR RECEPTOR;
UBIQUITIN;
UBIQUITIN PROTEIN LIGASE E3;
ANTIINFLAMMATORY ACTIVITY;
BINDING AFFINITY;
BINDING SITE;
CARCINOGENESIS;
CONFERENCE PAPER;
CYTOKINE RELEASE;
DIABETES MELLITUS;
DNA DAMAGE;
DRUG MECHANISM;
ENZYME ACTIVITY;
GENE EXPRESSION;
GENE FUNCTION;
GENETIC TRANSCRIPTION;
HUMAN;
INSULIN SENSITIVITY;
LYMPHATIC LEUKEMIA;
METABOLIC REGULATION;
MYELOID LEUKEMIA;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
SIGNAL TRANSDUCTION;
SUMOYLATION;
TRANSCRIPTION REGULATION;
UBIQUITINATION;
ANIMAL;
ARTICLE;
GENETICS;
INFLAMMATION;
METABOLISM;
NEOPLASM;
PHYSIOLOGY;
ANIMALS;
HUMANS;
INFLAMMATION;
NEOPLASMS;
NF-KAPPA B;
REACTIVE OXYGEN SPECIES;
SIGNAL TRANSDUCTION;
UBIQUITIN;
|
EID: 77950367756
PISSN: 1469221X
EISSN: 14693178
Source Type: Journal
DOI: 10.1038/embor.2010.36 Document Type: Conference Paper |
Times cited : (5)
|
References (9)
|